It has been a pleasure to share our work for the second year in a row at the AHA congress 2023. Thanks to @DMM_Journal for awarding me to attend #AHA2023#DMMgrants
La ivabradina induce cardioprotección previniendo la degradación de la matriz extracelular inducida por shock cardiogénico
#AheadOfPrint#REC#Cardiotwitter
https://t.co/CeZvUk7vO1
One more example of using NPs in CVD: Monitoring Vascular Permeability and Remodeling After Endothelial Injury in a Murine Model Using a Magnetic Resonance Albumin-Binding Contrast Agent | Circulation: Cardiovascular Imaging https://t.co/MNMwKIXvwm
https://t.co/V3KFMjYxWa
Another example of using NPs in CVD: EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction https://t.co/r60YzY6Vaj #Theranostics doi:10.7150/thno.13352
More examples of using NPs in CVD: Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide @MDPIOpenAccess https://t.co/G1ozRjuA2H https://t.co/s9f2QXkbWI
Great paper recently pubished with nanoparticles to reduce vascular inflammation: Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation | Circulation Research https://t.co/svsNAys0Dr
Extracellular Matrix preservation to avoid necrosis progresion of the heart
EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction https://t.co/r60YzY6Vaj #Theranostics
doi:10.7150/thno.13352
Un honor formar parte del @CIBER_CV en el artículo
CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions
Sci Rep 9, 20290 (2019)
https://t.co/RxburTlYRZ
Non invasive detection and measurement of myocardial infarction is now closer.
Nanotechnology Applied to Preserve Extracelular Matrix as Teranostic Tool in Acute Myocardial Infarction #REC https://t.co/lXwtbrRHty
doi: 10.1016/j.rec.2017.12.023